Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
2 other identifiers
observational
8
1 country
1
Brief Summary
The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 26, 2006
CompletedFirst Submitted
Initial submission to the registry
June 2, 2008
CompletedFirst Posted
Study publicly available on registry
June 5, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 26, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 26, 2012
CompletedJuly 6, 2018
July 1, 2018
6.6 years
June 2, 2008
July 3, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the expression of Fas protein in skin biopsies of participants with central centrifugal scarring alopecia (CCSA), lichen planopilaris (LP) and discoid lupus erythematosus (DLE) and in healthy controls.
8 weeks
Secondary Outcomes (1)
To evaluate the expression of Fas protein in skin biopsies of participants with central centrifugal scarring alopecia before and after treatment with intralesional and topical steroids.
8 weeks
Study Arms (3)
I
CCSA subjects will be recruited from patients who have been diagnosed through biopsy with CCSA and treated with standard of care for up to eight months in the Department of Dermatology clinic of Wake Forest University School of Medicine.
II
patients with lichen planopilaris (LP) and patients with discoid lupus erythematosus (DLE) will be collected from patients who have been diagnosed through biopsy in the clinic.
III
Healthy study subjects will be patients from the Wake Forest University School of Medicine Department of Dermatology population undergoing excisions for cosmetic purposes or excision of free margins around tumors that would have otherwise been discarded.
Eligibility Criteria
Wake Forest University Health Sciences Dermatology Clinic.
You may qualify if:
- Participants ages 30 years or older with a biopsy- proven diagnosis of CCSA.
- Undergone standard of care treatment for CCSA by a WFUSM Dermatologist
- Women of child bearing age will be required to have a negative pregnancy test in order to participate in the study
- Participants ages 30 years or older with a biopsy- proven diagnosis of LP.
- Participants ages 30 years or older with a biopsy- proven diagnosis of DLE.
- Healthy participants must be ages 30 years or older.
You may not qualify if:
- Age less than 30 years of age.
- Clinically evident bacterial or viral infection of the scalp.
- Pregnant or nursing woman of child-bearing potential.
- Participation in any other investigative research study involving study medication.
- Inability to return for the biopsy visit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest University Health Sciences Dermatology
Winston-Salem, North Carolina, 27157, United States
Biospecimen
Two, 4mm punch biopsies will be obtained of skin tissue.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy McMichael, MD
Wake Forest University Health Sciences
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2008
First Posted
June 5, 2008
Study Start
April 26, 2006
Primary Completion
November 26, 2012
Study Completion
November 26, 2012
Last Updated
July 6, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share